Articles

Tezepelumab for early-onset severe allergic asthma with persistent airflow limitation and small airway dysfunction: a treatable traits approach

Francesco Menzella, Claudio Sorino, Carlo Lombardi, Annamaria Bosi, Silvia Tonin, Lorenzo Corsi, Andrea Ballarin, Marcello Cottini

Article Type

Case Report & Review

Published

This article describes the clinical and functional evolution of a young patient with severe early-onset allergic asthma with impaired respiratory function treated with the anti-thymic stromal lymphopoietin biologic agent tezepelumab.

Read more

10 years of real-world data: long-term efficacy and safety of HyalOne® for hip osteoarthritis

Alberto Migliore, Nazzareno Iannarelli, Luca Saccone, Francesca Giovannangeli, Umberto Massafra, Orazio de Lucia, Annamaria Paglionico, Sergio Crimaldi, Eugenio Cunego, Raffaele Saporito, Gabriele al Khayyat Suhel, Giovanni Boni

Article Type

Original Research

Published

This study provides the first real-world evidence of the sustained efficacy and safety of a 10-year ultrasound-guided HyalOne® injection regimen in managing hip osteoarthritis, highlighting significant improvements in pain, function and non-steroidal anti-inflammatory
drug reduction across diverse patient populations.

Read more

Nurses’ perceptions on the usability of the Hyrimoz® Sensoready® autoinjector device

Charlotte Both, Elena Bachinskaya, Laura Rose, Carol M Antequera, Jessica R Allegretti

Article Type

Original Research

Published

This survey of gastroenterology nurses in the USA was designed to assess nurses’ perceptions regarding the Hyrimoz Sensoready pen, and the degree to which unique features might influence patient education when compared with the reference medicine autoinjector device, the Humira pen.

Read more

Real-world analysis of IL-23 inhibitors in patients with moderate-to-severe psoriasis and early musculoskeletal symptoms

Annunziata Dattola, Nicoletta Bernardini, Jasmine Anedda, Laura Atzori, Claudio Bonifati, Pier Luigi Bruni, Domenico Giordano, Dario Graceffa, Elisa Molinelli, Gaia Moretta, Cristina Mugheddu, Annamaria Offidani, Gianluca Pagnanelli, Sabatino Pallotta, Manuela Papini, Severino Persechino, Antonio Giovanni Richetta, Ersilia Tolino, Federica Trovato, Giovanni Pellacani, Concetta Potenza

Article Type

Original Research

Published

This article aims to evaluate the effect of IL-23 inhibitors on clinical outcomes and progression of PsA in patients with moderate-to-severe psoriasis and early musculoskeletal involvement.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.